[Predictive diagnostics of gastric cancer in 2018].

  title={[Predictive diagnostics of gastric cancer in 2018].},
  author={Ondřej Daum and Magdal{\'e}na Dubov{\'a} and Alena Sk{\'a}lov{\'a} and Tom{\'a}{\vs} Rozko{\vs} and Jan Laco},
  journal={Ceskoslovenska patologie},
  volume={54 1},
Anti-HER2 monoclonal antibody trastuzumab remains the only targeted therapy of gastric carcinoma based on histopathological predictive diagnostics used in current routine clinical practice. In the Czech Republic only the adenocarcinomas with HER2 immunohistochemical score of 3+, together with HER2 amplification detected with in situ hybridization are… CONTINUE READING